The paper “What outcomes are important to patients with mild cognitive impairment or Alzheimer’s disease, their caregivers, and health-care professionals? A systematic review.”, co-authored by Quantify’s Anders Gustavsson has been published in Alzheimer’s & Dementia.

The review identifies a wide range of important outcomes from the perspectives of patients, their caregivers and health-care professionals. They include hallmarks of AD including cognition and function but also other outcomes that are not commonly captured in clinical trials, such as access to health information and maintenance of identity.